Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Deva Holding AS's Accounts Payable for the quarter that ended in Mar. 2026 was ₺2,252 Mil.
Deva Holding AS's quarterly Accounts Payable
increased
from Sep. 2025 (₺1,553 Mil) to Dec. 2025 (₺2,696 Mil) but then
declined
from Dec. 2025 (₺2,696 Mil) to Mar. 2026 (₺2,252 Mil).
Deva Holding AS's annual Accounts Payable
increased
from Dec. 2023 (₺1,296 Mil) to Dec. 2024 (₺1,465 Mil) and
increased
from Dec. 2024 (₺1,465 Mil) to Dec. 2025 (₺2,696 Mil).
The historical data trend for Deva Holding AS's Accounts Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.
Deva Holding AS (IST:DEVA) has a Accounts Payable of ₺2,252 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Deva Holding AS and its competitors.
Is Deva Holding AS's Accounts Payable too high?
Deva Holding AS's current Accounts Payable is ₺2,252 Mil. Overall, Deva Holding AS has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Deva Holding AS's Accounts Payable compare to ZTS and UTHR?
Deva Holding AS's Accounts Payable of ₺2,252 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Deva Holding AS and its competitors. Deva Holding AS's current Accounts Payable is ₺2,252 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Deva Holding AS stock overvalued right now?
Based on GuruFocus' analysis, Deva Holding AS (IST:DEVA) is currently considered Modestly Undervalued. The stock's GF Value™ is ₺82.82, compared to a current price of ₺72.80 — trading 12.1% below its estimated fair value. The current Accounts Payable is ₺2,252 Mil. Deva Holding AS's overall GF Score™ is 63/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Deva Holding AS (IST:DEVA), the current Accounts Payable is ₺2,252 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Deva Holding AS (IST:DEVA) Overvalued in 2026?
Based on GuruFocus' analysis, Deva Holding AS stock appears to be undervalued.
The current stock price of ₺72.80 is trading 12.1% below its estimated GF Value™ of ₺82.82.
GuruFocus considers Deva Holding AS to be Modestly Undervalued.
Key valuation signals for IST:DEVA:
Accounts Payable: ₺2,252 Mil
GF Value™: ₺82.82 vs. price of ₺72.80 (12.1% below fair value)
No single metric tells the full story. See the IST:DEVA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Deva Holding AS is a Turkey-based generic medicine manufacturer. It is engaged in manufacturing and marketing of medicinal products for human use and raw materials. The company also carries out the manufacturing of veterinary drugs, eau de cologne, and medical ampoules. It produces medicines for antineoplastic agents, cardiovascular system, dermatological products, nervous system, respiratory system, urogenital system, among others. It exports pharmaceuticals and pharmaceutical raw materials in countries including Switzerland, Germany, the Netherlands, the United Kingdom and others.
63GF Score
Get the complete analysis for IST:DEVA
Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
IST:DEVA has been successfully added to your 
